Harrow gets CMS confirmation that IHEEZO is separately payable in physician office setting

HARROW, INC.

CMS confirmed IHEEZO's J-Code 2403 will be included in April 2024 quarterly ASP drug pricing file.
Separate payment for IHEEZO in physician offices applies under Medicare Part B beginning April 2024.
This regulatory milestone may improve IHEEZO adoption and reimbursement for Harrow (HROW).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.